Victory Capital Management Inc Omeros Corp Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$12.21 - $16.99 $106,617 - $148,356	-8,732 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$9.03 - $19.72 $13,662 - $29,836	-1,513 Reduced 14.77%	8,732 $117,000
Q4 2019 Feb 06, 2020	BUY	$13.01 - $17.15 $18,448 - $24,318	1,418 Added 16.06%	10,245 $144,000
Q4 2019 Feb 04, 2020	BUY	$13.01 - $17.15 $7,962 - $10,495	612 Added 7.45%	8,827 $113,000
Q3 2019 Nov 12, 2019	BUY	$14.55 - $20.56 $119,528 - $168,900	8,215 New	8,215 $134,000
Q1 2019 May 03, 2019	SELL	$11.65 - $17.72 $17,684 - $26,898	-1,518 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$10.72 - $16.73 $3,098 - $4,834	-289 Reduced 15.99%	1,518 $17,000
Q3 2018 Nov 01, 2018	BUY	$17.73 - $26.69 $4,202 - $6,325	237 Added 15.1%	1,807 $44,000
Q2 2017 Aug 07, 2017	BUY	N/A	1,570	1,570 $31,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.